An HA that's designed for safety2

Get Adobe Flash player

 

  • Euflexxa® has a long, single-HA structure similar to the HA in healthy human synovial fluid2
  • Euflexxa® is bioengineered and, unlike most other HA therapies, not derived from rooster combs2
    • Contains no avian proteins

 


Get Adobe Flash player

 

  • Less than 1% of patients receiving Euflexxa® experienced effusion compared with 8.1% of patients receiving Synvisc® (P=.0015)2
    • One effusion in a patient receiving Euflexxa® versus 15 effusions in 13 patients receiving Synvisc®
Reference: 1.Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthr Cartil. 2006;14:154-162. 2. Data on file. Bio-Technology General (Israel) Ltd-BTG.

spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer